aTyr Pharma Inc. (LIFE) News Headlines

▮ More

Date

Headline

9/29/2022 8:27:25 AM ATyr Pharma Announces Notice Of Allowance For U.S. Patent For Anti-Neuropilin-2 Monoclonal Antibodies

9/13/2022 8:46:27 AM ATyr Pharma Announces Second Fast Track Designation For Efzofitimod Clinical Program

9/13/2022 8:30:29 AM ATyr Pharma Gets FDA Fast Track Designation For Efzofitimod For Treatment Of Lung Disease

5/10/2022 5:45:15 AM ADCT Awaits Cami Trial Data, CSTL Boosts Revenue Outlook, ANNX To Report HD Trial Data In Q2

4/13/2022 10:00:50 AM ATyr Pharma Adds 7% On Receiving Orphan Drug Status For Its Lead Drug Candidate

9/16/2021 6:35:57 AM Pre-market Movers: LPTX, IRNT, AGIL, IO, INDP…

9/14/2021 10:13:11 AM ATyr Pharma Rally Continues On Positive Data From Clinical Trial Of Pulmonary Sarcoidosis

9/13/2021 12:46:30 PM ATyr Pharma Surges 40% On Positive Data From Pulmonary Sarcoidosis Drug Trial

9/13/2021 7:48:15 AM ATyr Pharma Announces Phase 1b/2a Trial Of ATYR1923 Meets Primary Endpoint

1/5/2021 6:01:14 AM Pre-market Movers In Healthcare Sector: CHEK, SYN, NSPR, ZOM, BNGO, VRAY...

Older Articles

Atyr Pharma Inc. (LIFE)